Semler Scientific, Inc. (NASDAQ:SMLR – Get Free Report) saw a significant drop in short interest in January. As of January 15th, there was short interest totalling 1,180,000 shares, a drop of 15.1% from the December 31st total of 1,390,000 shares. Approximately 15.7% of the shares of the stock are short sold. Based on an average daily trading volume, of 730,200 shares, the days-to-cover ratio is presently 1.6 days.
Institutional Trading of Semler Scientific
Several institutional investors and hedge funds have recently added to or reduced their stakes in SMLR. Dimensional Fund Advisors LP raised its holdings in Semler Scientific by 18.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 126,177 shares of the company’s stock worth $4,341,000 after purchasing an additional 19,552 shares during the last quarter. AQR Capital Management LLC raised its holdings in Semler Scientific by 150.1% during the 2nd quarter. AQR Capital Management LLC now owns 140,498 shares of the company’s stock worth $4,833,000 after purchasing an additional 84,314 shares during the last quarter. Newbridge Financial Services Group Inc. bought a new stake in Semler Scientific during the 2nd quarter worth about $34,000. Shariaportfolio Inc. acquired a new position in shares of Semler Scientific during the 3rd quarter worth about $3,618,000. Finally, Pinnacle Associates Ltd. grew its position in shares of Semler Scientific by 83.9% during the 3rd quarter. Pinnacle Associates Ltd. now owns 29,346 shares of the company’s stock worth $691,000 after buying an additional 13,392 shares during the period. 49.37% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Separately, Lake Street Capital raised their target price on Semler Scientific from $40.00 to $71.00 and gave the company a “buy” rating in a research note on Friday, January 24th.
Semler Scientific Price Performance
Shares of NASDAQ:SMLR traded down $1.50 during midday trading on Monday, reaching $50.46. The company’s stock had a trading volume of 464,280 shares, compared to its average volume of 489,136. Semler Scientific has a fifty-two week low of $20.88 and a fifty-two week high of $81.56. The company has a market capitalization of $467.61 million, a P/E ratio of 24.61 and a beta of 1.18. The business’s fifty day simple moving average is $59.98 and its 200-day simple moving average is $41.01.
Semler Scientific (NASDAQ:SMLR – Get Free Report) last announced its quarterly earnings data on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.35. The firm had revenue of $13.51 million during the quarter. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%.
About Semler Scientific
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.
Recommended Stories
- Five stocks we like better than Semler Scientific
- What Does Downgrade Mean in Investing?
- How to Invest in Small Cap Stocks
- Russell 2000 Index, How Investors Use it For Profitable Trading
- These Are the Dividend Stocks Insiders Bought in January
- What Are Some of the Best Large-Cap Stocks to Buy?
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.